NDC11 72789045701
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 72789-0457-01 | 72789-0457 |
| 72789-0457-1 | 72789-0457 |
| 72789-457-01 | 72789-457 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CEVIMELINE HYDROCHLORIDE | CEVIMELINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2b429ea7-1c7c-47a4-803c-2546736f5c36 | 2026-08-27 | Warnings, Adverse reactions | 72789-457-01 72789-457 72789045701 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.